Last updated on August 2007

Genetic Abnormalities and Biological Changes of Panic Disorder Patients After Pharmacotherapy

Brief description of study

We plan to examine genetic polymorphism of catechol-O-methyltransferase in panic disorder and neurobiological changes of panic disorder patients after 12 weeks of pharmacotherapy with paroxetine. We plan to include 40 panic disorder patients and 40 normal control subjects in this study for 3 years.

Clinical Study Identifier: NCT00515996

Contact Investigators or Research Sites near you

Start Over

Bum-Hee Yu, M.D. & Ph.D.

Samsung Medical Center
Seoul, Korea, Republic of
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.